Lasa Supergenerics Limited

Founded in 2016 and headquartered in Maharashtra, India.

2016 | Ratnagiri, Maharashtra (India) | Active
Last Updated:

Lasa Supergenerics Profile

Key Indicators

  • Authorised Capital ₹ 100.33 Cr
  • Paid Up Capital ₹ 50.10 Cr
  • Company Age 9 Year, 1 Month
  • Last Filing with ROC 31 Mar 2024
  • Satisfied Charges ₹ 84.64 Cr
  • Revenue Growth -4.24%
  • Profit Growth -619.57%
  • Ebitda -142.18%
  • Net Worth -20.42%
  • Total Assets -17.75%

About Lasa Supergenerics

Lasa Supergenerics Limited (LSL) is a Public Limited Indian Non-Government Company incorporated in India on 11 March 2016 (Nine years and one month 15 days old ). Its registered office is in Ratnagiri, Maharashtra, India.

It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 540702 and on the National Stock Exchange(NSE) under LASA.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 100.33 Cr and a paid-up capital of Rs 50.10 Cr.

The company has closed loans amounting to ₹84.64 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.

The Key Managerial Personnel (KMP) at Lasa Supergenerics Limited India are Mitti Jain as COMPANY SECRETARY and Varsha Joshi as Cfo. Omkar Pravin, Hardesh Tolani, Ajay Sukhwani, and Three other members serve as directors at the Company.

Company Details

  • Location

    Ratnagiri, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    L24233MH2016PLC274202

  • Company No.

    274202

  • Stock Symbol

    BSE : 540702 NSE : LASA

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    11 Mar 2016

  • Date of AGM

    27 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Listed

  • ROC Code

    Roc Mumbai

Industry

Pharma

What products or services does Lasa Supergenerics Limited offer?

Lasa Supergenerics Limited offers a wide range of products and services, including Insecticides and Pesticides, Acaricide, Veterinary Medicines, Veterinary Chemicals, Animal Medicines & Health Care, Anthelmintics, Antibacterial Drugs, Ofloxacin Ornidazole Tablets, Hand Sanitizers & Personal Hygiene, Antiseptic Liquid & Cream.

Company report

Lasa Supergenerics Limited

Explore comprehensive data for Lasa Supergenerics Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Lasa Supergenerics?

Executive Team (3)

NameDesignationAppointment DateStatus
Omkar Pravin Country flag representing In Managing Director11-Mar-2016Current
Mitti Jain Company Secretary21-Mar-2023Current
Varsha Joshi CFO01-Aug-2024Current

Board Members (5)

NameDesignationAppointment DateStatus
Manali Bhagtani Country flag representing In Director 15-May-2018Current
Hardesh Tolani Country flag representing In Director 02-May-2017Current
Ajay Sukhwani Country flag representing In Director 02-May-2017Current
Umesh Pawar Country flag representing In Whole-Time Director 08-Mar-2024Current
Ekta Gurnasinghani Country flag representing In Director 02-May-2017Current

Financial Performance of Lasa Supergenerics.

Lasa Supergenerics Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 4.24% decrease. The company also saw a substantial fall in profitability, with a 619.57% decrease in profit. The company's net worth observed a substantial decline by a decrease of 20.42%.

Lasa Supergenerics revenue growth over time
Lasa Supergenerics profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-4.24%
Revenue from Operations
-5.51%
Total Assets
-17.75%
Profit or Loss
-619.57%
Net Worth
-20.42%
EBITDA
-142.18%

What is the Ownership and Shareholding Structure of Lasa Supergenerics?

In 2023, Lasa Supergenerics had a promoter holding of 53.65% and a public holding of 46.35%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹0

Satisfied Charges

₹84.64 Cr

Charges Breakdown by Lending Institutions

  • Axis Bank Limited : 76.79 Cr
  • Others : 7.85 Cr

Latest Charge Details

DateLenderAmountStatus
26 Apr 2018Others₹6.03 CrSatisfied
31 Mar 2018Others₹1.82 CrSatisfied
28 Nov 2012Axis Bank Limited₹76.79 CrSatisfied

How Many Employees Work at Lasa Supergenerics?

Lasa Supergenerics has a workforce of 326 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Lasa Supergenerics Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Lasa Supergenerics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lasa Supergenerics's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Lasa Supergenerics

Recent activity within the organization

  • Annual General Meeting

    Lasa Supergenerics Limited last Annual general meeting of members was held on 27 Sep 2024 as per latest MCA records.

  • Director Appointment

    Varsha Pravin Joshi was appointed as a Cfo was appointed as a Cfo on 01 Aug 2024 & has been associated with this company since 8 months 25 days .

  • Balance Sheet

    Lasa Supergenerics Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.

  • Director Appointment

    Umesh Shankar Pawar was appointed as a Whole-Time Director was appointed as a Whole-Time Director on 08 Mar 2024 & has been associated with this company since 1 year 1 month .

  • Charges

    A charge registered on 28 Nov 2012 via Charge ID 10391228 with Axis Bank Limited was fully satisfied on 02 Dec 2023.

  • Charges

    A charge registered on 31 Mar 2018 via Charge ID 100170282 with Others was fully satisfied on 20 Mar 2021.

Frequently asked questions

  • What is the Incorporation or founding date of Lasa Supergenerics Limited?

    Lasa Supergenerics Limited was incorporated on 11 Mar 2016.

  • What is authorized share capital and paid-up capital of Lasa Supergenerics Limited?

    The authorized share capital of Lasa Supergenerics Limited is ₹ 100.33 Cr and paid-up capital is ₹ 50.10 Cr.

  • Who are the current board members & directors of Lasa Supergenerics Limited?

    Currently 8 directors are associated with Lasa Supergenerics Limited.

    • Omkar Herlekar Pravin
    • Hardesh Raja Tolani
    • Ajay Hareshlal Sukhwani
    • Manali Roop Bhagtani
    • Umesh Shankar Pawar
    • Mitti Jain
    • Varsha Pravin Joshi
    • Ekta Avtar Gurnasinghani

  • What is the registered address of Lasa Supergenerics Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Lasa Supergenerics Limited is Plot No. C-4 C-4/1 Midc Lote Parshuram Industrial Area Tal -Khe D, India, Khed, Maharashtra, 415722.

  • What is the corporate identification number (CIN) and company number of Lasa Supergenerics Limited?

    The corporate identification number (CIN) of Lasa Supergenerics Limited is L24233MH2016PLC274202 and the company number is 274202 as per Ministry of Corporate Affairs (MCA).

  • Is Lasa Supergenerics Limited registered with any stock exchange in India?

    Yes, Lasa Supergenerics Limited is registered on Bombay Stock Exchange (BSE) and National Stock Exchange (NSE): LASA.

  • What is the official website of Lasa Supergenerics Limited?

    The Official website of Lasa Supergenerics Limited is https://www.lasalabs.com

  • What has been the recent revenue trend for Lasa Supergenerics Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Lasa Supergenerics Limited has fallen by -4.24%.

  • How many employees does Lasa Supergenerics Limited currently have?

    As Per 2023 financial reports, 326 employees are currently employed by Lasa Supergenerics Limited.

  • What change has been observed in the net worth of Lasa Supergenerics Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Lasa Supergenerics Limited has experienced an downturn of -20.42%.

  • When was the last Balance Sheet of Lasa Supergenerics Limited filed with the ROC?

    The most recent Balance Sheet for Lasa Supergenerics Limited was filed with the ROC on 31 Mar 2024.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Animal Pharmaceuticals & Healthcare